"use strict";(self.webpackChunkpca=self.webpackChunkpca||[]).push([[114],{5114:(q,T,a)=>{a.r(T),a.d(T,{DiabetesModule:()=>K});var p=a(6895),I=a(5730),M=a(1583);const D={initial:{question:"What is the patient's eGFR?",next:"risks"},risks:{question:"Select any of the following that applies to the patient",next:"displayMedSuggestions"},displayMedSuggestions:{}},b=[{authors:["Buse JB","Wexler DJ","Tsapas A","Rossing P","Mingrone G","Mathieu C","D'Alessio DA","Davies MJ"],title:"2019 update to: Management of hyperglycemia in type 2 diabetes, 2018.  A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",link:"https://diabetesjournals.org/care/article/43/2/487/36098/2019-Update-to-Management-of-Hyperglycemia-in-Type",pages:"487-493",citationType:"journal",year:"2020",journalName:"Diabetes Care",volume:"43",issue:"2",isOnline:!0,doi:"https://doi.org/10.2337/dci19-0066"}];var r=a(369);const g={displayText:"GLP-1 receptor agonists",comment:{title:"List of GLP-1 agonists for diabetes (alphabetical order)",body:`\n            <ul>\n                ${(0,r.Pv)(["Trulicity (dulaglutide, subQ weekly)","Bydureon Bcise (exenatide, subQ weekly)","Byetta (exenatide, subQ BID, seldom used)","Ozempic (semaglutide, subQ weekly)","Victoza (liraglutide, subQ daily)","Adlyxin (lixisenatide, subQ daily)","Rybelsus (semaglutide, PO daily)","Mounjaro (tirzepatide, subQ weekly, combined GLP1/GIP agonist)"].sort())}\n            </ul>\n            <br/>\n            <p>Note: These medications are contraindicated\n            in the setting of personal or family history of \n            medullary thyroid cancer or multiple endocrine\n            neoplasia 2 (MEN 2).</p>\n        `}},l={displayText:"SGLT2 inhibitors",comment:{title:"List of SGLT2 inhibitors (alphabetical order)",body:`\n            <ul>\n                ${(0,r.Pv)(["Jardiance (empagliflozin, ineffective if eGFR <30)","Invokana (canagliflozin, ineffective if eGFR <30)","Farxiga (dapagliflozin, ineffective if eGFR <45)","Steglatro (ertugliflozin, ineffective if eGFR <45)"].sort())}\n            </ul>\n            <br/>\n            <p>Note: Side effects that have been seen \n            with this class include volume depletion,\n            genital mycotic infections, UTIs/urosepsis,\n            increased lower-limb amputation rate,\n            ketoacidosis, necrotizing fasciitis,\n            increased bone fracture risk</p>\n        `}},c={displayText:"DPP4 inhibitors",comment:{title:"List of DPP4 inhibitors (alphabetical order)",body:`\n            <ul>\n                ${(0,r.Pv)(["Nesina (alogliptin)","Januvia (sitagliptin)","Tradjenta (linagliptin)","Onglyza (saxagliptin)"].sort())}\n            </ul>\n            <br/>\n            <p>\n                Note: Avoid this class if already on a \n                GLP-1 agonist.  Avoid saxagliptin in heart failure.\n            </p>\n        `}},m={displayText:"Basal insulin",comment:{title:"List of basal insulins (alphabetical order)",body:`\n            <ul>\n                ${(0,r.Pv)(["glargine (Lantus, Basaglar, Toujeo, Semglee)","NPH (Novolin N, Humulin N)","detemir (Levemir)","degludec (Tresiba)"].sort())}\n            </ul>\n            <br/>\n        `}},h={displayText:"Thiazolidinediones (TZDs)",comment:{title:"List of TZDs",body:`\n            <ul>\n                ${(0,r.Pv)(["pioglitazone (Actos)"].sort())}\n            </ul>\n            <br/>\n            <p>\n                Note: Avoid in CHF and bladder cancer. Can cause fluid retention,\n                increased bone fracture risk, weight gain, hepatitis.\n                Avandia (rosiglitazone) is still on the market\n                in the U.S. but associated with increased cardiovascular\n                events. Withdrawn from the market in many countries.  \n            </p>\n        `}},d={displayText:"Sulfonylureas",comment:{title:"List of 2nd generation sulfonylureas (alphabetical order)",body:`\n            <ul>\n                ${(0,r.Pv)(["glimepiride","glipizide","glyburide"].sort())}\n            </ul>\n            <br/>\n        `}},C=[g,l,c,d,m,h],_=[l,g,c,d,m],E=[d,h,m,c,l],P=[g,l,c,h,d,m],Z=[g,l,c,d,m,h],N=[{name:"History of atherosclerotic cardiovascular disease (ASCVD)",isChecked:!1},{name:"Age > 55 years + LVH or coronary, carotid, or lower extremity artery stenosis > 50%",isChecked:!1},{name:"Congestive heart failure",isChecked:!1},{name:"Urine albumin/creatinine ratio (UACR) > 30mg/g",isChecked:!1},{name:"Cost is a major issue",isChecked:!1},{name:"Compelling need to minimize weight gain or promote weight loss",isChecked:!1},{name:"Compelling need to minimize hypoglycemia",isChecked:!1}];var e=a(4650),k=a(455),A=a(1948),f=a(4006),O=a(7612),R=a(6903);function U(i,o){if(1&i&&(e.TgZ(0,"mat-radio-button",7),e._uU(1),e.TgZ(2,"sup"),e._uU(3,"2"),e.qZA()()),2&i){const t=o.$implicit;e.Q6J("value",t),e.xp6(1),e.hij(" ",t.number," ml/min/1.73 m")}}function J(i,o){if(1&i){const t=e.EpF();e.TgZ(0,"section")(1,"mat-radio-group",5),e.NdJ("change",function(){e.CHM(t);const u=e.oxw();return e.KtG(u.gfrChanged())})("ngModelChange",function(u){e.CHM(t);const s=e.oxw();return e.KtG(s.selectedEGFR=u)}),e.YNc(2,U,4,2,"mat-radio-button",6),e.qZA()()}if(2&i){const t=e.oxw();e.xp6(1),e.Q6J("ngModel",t.selectedEGFR),e.xp6(1),e.Q6J("ngForOf",t.egfrGroups)}}function H(i,o){if(1&i){const t=e.EpF();e.TgZ(0,"div")(1,"mat-slide-toggle",9),e.NdJ("change",function(){const s=e.CHM(t).index,y=e.oxw(2);return e.KtG(y.historicalFeatureChanged(s))}),e.qZA(),e._uU(2," \xa0 "),e.TgZ(3,"span"),e._uU(4),e.qZA()()}if(2&i){const t=o.$implicit;e.xp6(1),e.Q6J("color","#009688")("checked",t.isChecked),e.xp6(3),e.hij(" ",t.name," ")}}function Q(i,o){if(1&i&&(e.TgZ(0,"section"),e.YNc(1,H,5,3,"div",8),e.qZA()),2&i){const t=e.oxw();e.xp6(1),e.Q6J("ngForOf",t.historicalFeatures)}}function B(i,o){1&i&&(e.TgZ(0,"li"),e._uU(1,"Metformin"),e.qZA())}const z=function(i){return{comment_link:i}};function w(i,o){if(1&i){const t=e.EpF();e.TgZ(0,"ul")(1,"li",10),e.NdJ("click",function(){const s=e.CHM(t).$implicit,y=e.oxw(2);return e.KtG(null!=s.comment&&s.comment.body?y.displayComments(s.comment):null)}),e._uU(2),e.qZA()()}if(2&i){const t=o.$implicit;e.xp6(1),e.Q6J("ngClass",e.VKq(2,z,null==t.comment?null:t.comment.body)),e.xp6(1),e.Oqu(t.displayText)}}function Y(i,o){if(1&i&&(e.TgZ(0,"section")(1,"p"),e._uU(2,"These are the classes of diabetes medications displayed in order of preference, based on your selections:"),e.qZA(),e.TgZ(3,"ul"),e.YNc(4,B,2,0,"li",3),e.qZA(),e.YNc(5,w,3,4,"ul",8),e.qZA()),2&i){const t=e.oxw();e.xp6(4),e.Q6J("ngIf",t.useMetformin),e.xp6(1),e.Q6J("ngForOf",t.commentItemArray)}}let j=(()=>{class i extends M.k{constructor(){super(...arguments),this.sectionMapper=D,this.citations=b,this.dateLastUpdated="11/06/2022",this.algoPurpose="Determine type 2 diabetes medications to use based on patient characteristics",this.algoNote="Comprehensive lifestyle management (including weight management and physical activity) is considered first-line for all patients.",this.egfrGroups=I.C,this.historicalFeatures=N,this.commentItemArray=[],this.prevCommentItemArray=[],this.useMetformin=!0,this.useSGLT2s=!0,this.mildckd=!1}historicalFeatureChanged(t){super.historicalFeatureChanged(t),this._getCommentItemArray()}_getCommentItemArray(){this.commentItemArray=[];let t=!1;for(let n of this.historicalFeatures)if(n.isChecked){if(t=!0,n.name.includes("ASCVD")||n.name.includes("55 years")){this.commentItemArray=C;break}if(n.name.includes("Congestive heart failure")||n.name.includes("albumin")){this.commentItemArray=_;break}if(n.name.includes("Cost")){this.commentItemArray=E;break}if(n.name.includes("hypoglycemia")){this.commentItemArray=P;break}if(n.name.includes("weight")){this.commentItemArray=Z;break}}t||(this.commentItemArray=C),this.prevCommentItemArray=this.commentItemArray,this._adjustSGLT2(this.prevCommentItemArray),this._removeTZDIfCHF()}_GFRIsBelow(t){return this.selectedEGFR.minVal<t}gfrChanged(){this.useMetformin=!this._GFRIsBelow(30),this.useSGLT2s=!this._GFRIsBelow(30),this.mildckd=this._GFRIsBelow(60)&&!this._GFRIsBelow(30),this._adjustSGLT2(this.prevCommentItemArray),!this.commentItemArray.length&&this.mildckd&&(this.commentItemArray=_)}_adjustSGLT2(t){this.commentItemArray&&!this.useSGLT2s?this.commentItemArray=this.commentItemArray.filter(n=>!n.displayText.includes("SGLT2")):this.commentItemArray&&(this.commentItemArray=t)}_removeTZDIfCHF(){for(let t of this.historicalFeatures)t.name.includes("Congestive heart failure")&&t.isChecked&&(this.commentItemArray=this.commentItemArray.filter(n=>!n.displayText.includes("TZD")))}}return i.\u0275fac=function(){let o;return function(n){return(o||(o=e.n5z(i)))(n||i)}}(),i.\u0275cmp=e.Xpm({type:i,selectors:[["app-type2-dm-management"]],features:[e.qOj],decls:8,vars:6,consts:[[3,"constData"],[1,"algo_content"],[1,"algo_content_main"],[4,"ngIf"],[3,"constData","disabled"],["color","primary",1,"radio-group",3,"ngModel","change","ngModelChange"],["class","radio-button",3,"value",4,"ngFor","ngForOf"],[1,"radio-button",3,"value"],[4,"ngFor","ngForOf"],["tabindex","0",1,"slide_toggle",3,"color","checked","change"],[3,"ngClass","click"]],template:function(t,n){1&t&&(e.TgZ(0,"main"),e._UZ(1,"app-algo-header",0),e.TgZ(2,"div",1)(3,"div",2),e.YNc(4,J,3,2,"section",3),e.YNc(5,Q,2,1,"section",3),e.YNc(6,Y,6,2,"section",3),e.qZA()(),e._UZ(7,"app-algo-footer",4),e.qZA()),2&t&&(e.xp6(1),e.Q6J("constData",n.constData),e.xp6(3),e.Q6J("ngIf","initial"===n.curSection),e.xp6(1),e.Q6J("ngIf","risks"===n.curSection),e.xp6(1),e.Q6J("ngIf","displayMedSuggestions"===n.curSection),e.xp6(1),e.Q6J("constData",n.constData)("disabled",!n.selectedEGFR))},dependencies:[p.mk,p.sg,p.O5,k.Rr,A.VQ,A.U0,f.JJ,O.h,R.y,f.On],encapsulation:2}),i})();var V=a(9299),$=a(6432);const W=[{path:"type2-dm-management",component:j}];let K=(()=>{class i{}return i.\u0275fac=function(t){return new(t||i)},i.\u0275mod=e.oAB({type:i}),i.\u0275inj=e.cJS({imports:[p.ez,V.Bz.forChild(W),$.m,f.u5]}),i})()}}]);